NCT05392881Recruiting
Interstitial Lung Disease Research Unit Biobank
University of Kansas Medical Center
Start Date
8/9/2021
Completion Date
3/1/2032
Summary
Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.
Detailed Description
The University of Kansas ILD and Rare Lung Disease clinic sees hundreds of new patients per year. The investigators would like to leverage this resource to develop an Interstitial Lung Disease Research Unit (ILDRU) repository and database to help develop new methods for early diagnosis, uncover underlying genetic and environmental risk factors, as well as potential treatment targets in the broad range of interstitial lung diseases and rare lung diseases (RLD).
Eligibility Criteria
Age Range: 18 years to No maximum
Inclusion Criteria:
1. The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP)
2. The participant is being followed for the presence of autoimmune disease, ILD or other rare lung diseases at TUKHS.
3. The participant is ≥ 18 years of age.
4. The participant has signed an approved consent for this study (living patients only)
Conditions
Interstitial Lung DiseaseSarcoidosisIdiopathic Pulmonary FibrosisPulmonary FibrosisHypersensitivity Pneumonitis
Locations
The University of Kansas Medical Center
Kansas City, Kansas 66160
United States